292 results
Page 10 of 15
8-K
vjivlc5tu
17 May 11
Dose-related efficacy and optimal once-daily dosing interval of the long-acting beta2
12:00am
8-K
EX-99
ojwo uqkqf6e
28 Apr 11
Results of Operations and Financial Condition
12:00am
8-K
EX-99
t2gys 86dkp5vuk
15 Feb 11
Results of Operations and Financial Condition
12:00am
8-K
EX-99
j6xw epd9a5
3 Feb 11
Other Events
12:00am
8-K
6wgpbl tba42ip
3 Feb 11
Other Events
12:00am
8-K
EX-99.1
tjzpt4fp1cu hz4
12 Jan 11
Regulation FD Disclosure
12:00am
8-K
8vndxw6hvlap5bhtf9y
21 Dec 10
Other Events
12:00am
8-K
EX-99
v0prpd7wa54lr
21 Dec 10
Other Events
12:00am
8-K
EX-99.1
93pn45d
29 Nov 10
GlaxoSmithKline to Increase Its Shareholding in Theravance
12:00am
8-K
EX-99.2
80ceq k2u
21 Oct 10
Theravance Announces Positive Results from Phase 1 and Phase 2 Clinical Studies with TD-1211 in Development
12:00am
8-K
EX-99.1
p2ieyo
21 Oct 10
Theravance Announces Positive Results from Phase 1 and Phase 2 Clinical Studies with TD-1211 in Development
12:00am
8-K
EX-99
1sc4de8bcvlaj j26
21 Oct 10
Results of Operations and Financial Condition
12:00am
8-K
9q9yh8tpsckob
22 Sep 10
Other Events
12:00am
8-K
h8434b47s
22 Sep 10
Other Events
12:00am
8-K
EX-99
a8ij4i nf5339bx
22 Sep 10
Other Events
12:00am
8-K
k17i7ahobi4852 szf3
20 Sep 10
Fluticasone furoate (FF), a novel inhaled corticosteroid (ICS), demonstrates once-daily efficacy in asthma when dosed in the evening
12:00am
8-K
EX-99.1
2zfyts 4efwcs9yd
20 Sep 10
Fluticasone furoate (FF), a novel inhaled corticosteroid (ICS), demonstrates once-daily efficacy in asthma when dosed in the evening
12:00am